Lina Kaminski

Lina is a principal at Pontifax, involved in identifying and evaluating new investment opportunities.
Prior to joining Pontifax, Lina was an equity research analyst at Canaccord Genuity and JonesTrading in New York, where she focused on rare disease and gene therapy biotech companies.
Lina obtained her PhD from Ben Gurion University, studying glycosylation in Archaea, and completed four years of a postdoctoral fellowship at Albert Einstein College of Medicine in New York, where she researched persistence mechanisms in Tuberculosis